![Tim Denison](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tim Denison is the founder of Verity Technologies, Inc., Amber Therapeutics Ltd. Dr. Denison is currently the Director at ONWARD Medical NV, starting in 2025.
Dr. Denison's education includes graduate and doctorate degrees from the Massachusetts Institute of Technology, and undergraduate and MBA degrees from The University of Chicago.
| Unternehmen | Position | Beginn |
|---|---|---|
| ONWARD MEDICAL N.V. | Direktor/Vorstandsmitglied | 07.07.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
Amber Therapeutics Ltd.
 Amber Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures closed-loop neuromodulation therapies | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GTX medical BV
 GTX medical BV Medical SpecialtiesHealth Technology Develops novel therapies for improved rehabilitation of patients suffering from spinal-cord injuries | Health Technology |
Amber Therapeutics Ltd.
Amber Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures closed-loop neuromodulation therapies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
